Abramovitch and Hey, "Internuclear cyclisation. Part VIII. Naphth[3:2:1-cd]oxindoles," J. Chem. Soc. 1697-1703 (1954), Strand, London.
Abramovitch et al., "A Novel Synthesis of a Cyclic Hydroxamic Acid Involving a Molecular Rearrangement," Chemistry and Industry 44:1871 (1967) 8Laporte Industries Limited, Lancashire.
Akbasak and Sunar-Akbasak, "Oncogenes: cause or consequence in the development of glial tumors," J. Neurol. Sci. 111:119-133 (1992)8 Elsevier Science Publishers.
Andreani et al., "In Vivo Cardiotonic Activity of Pyridylmethylene-2-indolinones," Arzneimittel-Forschung Drug Research 48:727-729 (1998) 8.
Andreani et al., "Potential Antitumor Agents. 25[1]. Synthesis and Cytotoxic Activity of 3-(2-Chloro-3-Indolymethylene)1,3-Dihydroindol-2-Ones," Anticancer Research 16:3585-3588 (1996) 8 Elsevier, Paris.
Andreani et al., "Synthesis and cardiotonic activity of 2-indolinones bearing pyridyl groups," Eur. J. Med. Chem. 28:653-657 (1993) 8 Elsevier, Paris.
Andreani et al., "Synthesis and cardiotonic activity of 2-indolinones," Chemical Abstracts, vol. 113, abstract No. 78106 (1990).
Andreani et al., "Synthesis and cardiotonic activity of 2-indolinones," Eur. J. Med. Chem. 25:187-190 (1990).
Andreani et al., "Synthesis and cardiotonic activity of pyridylmethylene-2-indolinones," Eur. J. Med. Chem. 27:167-170 (1992) 8 Elsevier, Paris.
Andreani et al., "Synthesis and potential coanthracyclinic activity of substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-Indolinones," Eur. J. Med. Chem. 32:919-924 (1997)8 Elsevier, Paris.
Andreani et al., "Synthesis of lactams with potential cardiotonic activity," Eur. J. med. Chem. 28:825-829 (1993).M
Arteaga et al., "Blockade of the Type I Somatomedin Receptor Inhibits Growth of Human Breast Cancer Cells in Athymic Mice," J. Clin. Invest. 84:1418-1423 (1989) copyright The American Society for Clinical Investigation, Inc.
Arvidsson et al., "Tyr-716 in the Platelet-Derived Growth Factor beta-Receptor Kinase Insert is Involved in GRB2 Binding and Ras Activation," Molecular and Cellular Biology 14:6715-6726, 1994.
Autrey and Tahk, "The Synthesis and Sterochemistry of Some Isatylideneacetic Acid Derivatives," Tetrahedron 23:901-917 (1967) 8Pergamon Press.
Bahner and Brotherton, "6-Dimethylaminochrysene and Other Analogs of 4-(4-Dimethylamino)stilbene," J. Med. Chem. 12:722-723 (1969).
Bahner et al., "Benzylideneindenes with Oxygen Attached to the Indene Ring," J. Med. Chem. 12:721-722 (1969).
Bamfield et al., "Diels-Alder Reactions of Oxindolylideneacetone," J. Chem. Soc (C) 1028-1030 (1966) 8.
Barbier, et al., "Synthesis of Isobrassilexin, A Biologically Active Isomer of Brassilexin, a Cruciferae Phytoalexin," Synthetic Communications 23(22):3109-3117 (1993) 8 Marcel Dekker, Inc.
Baserga, "Oncogenes and the Strategy of Growth Factors," Cell 79:927-930 (1994) 8 Cell Press.
Baserga, "The Insulin-like Growth Factor I Receptor: A Key to Tumor Growth?" Cancer Research 55:249-252 (1995).
Beilstein Reg. No. 233511 (1997).
Beilstein Reg. No. 235647 (1997).
Beilstein Reg. No. 236050, Beilstein Reference No. 4-21-00-06355, year not available.
Beilstein Reg. No. 252929 (1998).
Benzies, et al., "2-Formyl-3-Methoxymethylindole, 3-Ethoxymethyl-2-Formylindoline and 2-Formyl-3-Methylindole," Synthetic Communications: 16(14), 1799-1807 (1986) 8 Mercel Dekker, Inc.
Blake and Jaques, "Anisotropic Effects in alpha-Substituted Methoxystilbenes," J. Chem. Soc. Perkin II: 1660-1663 (1973) 8 Pergamon, Oxford.
Bolen et al., "The Src family of tyrosine protein kinases in hemopoietic signal transduction," FASEB J. 6:3403-3409 (1992).
Bolen, "Nonreceptor tyrosine protein kinases," Oncogene 8:2025-2031 (1993) copyright MacMillan Press Ltd.
Bonner et al., "Structure and Biological Activity of Human Homologs of the raf/mil Oncogene," Molecular and Cellular Biology 5:1400-1407 (1985) 8 The American Society for Microbiology.
Borsche et al., "Ãœber vielkernige kondensierte Systeme mit heterocyclischen Ringen. XIII.," Liebigs Ann. Chem. 550:160-174 (1941).
Buzzetti et al., "Cinnamamide Analogs as Inhibitors of Protein Tyrosine Kinases," II Farmaco 48:615-636 (1993).
Cance et al., "Novel Protein Kinases Expressed in Human Breast Cancer," Int. J. Cancer 54:571-577 (1993) 8 Wiley-Liss, Inc.
Canoira and Rodriguez, "Synthesis of Oxindole Derivatives from N-Alkenyl-o-Chloroanilides with Zero-Valent Nickel Complex," J. Heterocyclic Chem. 1511-1518 (1985).
Carpenedo et al., "Identification and Measurement of Oxindole (2-Indolinone) in the Mammalian Brain and Other Rat Organs," Analytical Biochemistry 244:74-79 (1997) 8 Academic Press, Inc.
Chao, "Growth Factor Signaling: Where Is the Specificity?" Cell 68:995-997 (1992) copyright Cell Press.
Chatten et al., "Substituted Oxindoles. Part VI. Polarographic Reduction of Substituted trans-3-Benzylideneindol-2(3H)-ones," J. Chem. Soc. Perkin II: 469-473 (1973).
Chatterjee, et al., "Acylation of Indoles by Duff Reaction and Vilsmeier-Haack Formylation and Conformation of N-Formylindoles," J. Org. Chem., 38:4002-4004 8The American Chemical Society, 1973.
Chen et al., "Effects of 3,3-Dipyridylmethyl-1-Phenyl-2-Indolinone on gamma-Aminobutyric Acid Elicited Chloride Current of Snail Central Neuron," Chinese Journal of Physiology 40:149-156 (1997).
Claesson-Welsh, "Signal Transduction by the PDGF Receptors," Progress in Growth Factor Research 5:37-54 (1994) 8 Elsevier Science Ltd.
Coda et al., "(Z)- and (E)-Arylidene-1,3-dihydroindol-2-ones: Configuration, Conformation and Infrared Carbonyl Stretching Frequencies," J. Chem. Soc. Perkin Trans. II: 615-619 (1984).
Coda et al., "3-(4-methylbenzilidene)-1,3-dihydroindol-2-one," Journal of the Chemical Society, Perkin Transactions 2 4:615-620 (1984) Database Crossfire, Beilstein Reference No. 6-21.
Coppola et al., "A Fuunctional Insulin-Like Growth Factor I Receptor Is Required for the Mitogenic and Transforming Activities of the Epidermal Growth Factor Receptor," Molecular and Cellular Biology 14:4588-4595 (1994) 8 The American Society for Microbiology.
Daisley and Walker, "Thin-layer chromatographic separation of some substituted 3-benzylidine-indol-2(3H)-ones,"J. Chromatography 100:240-242 (1974) 8 Elsevier Scientific Publishing Company.
Damiani et al., "Inhibition of Copper-Mediated Low Density Lipoprotein Peroxidation by Quinoline and Indolinone Nitroxide Radicals," Biochemical Pharmacology 48:1155-1161 (1994) copyright Elsevier Science Ltd.
Dati et al., "Inhibition of c-erbB-2 oncogene expression by estrogens in human breast cancer cells," Oncogene 5:1001-1006 (1990).
Davis et al., "Synthgesis and Microbiological Properties of 3-Amino-1-Hydroxy-2-Indolinone and Related Compounds," Journal of Medicinal Chemistry 16:1043-1045 (1973) 8American Chemical Society.
De Vries et al., "The fms-Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth Factor," Science 255:989-991 (1992).
Decker and Lohmann-Matthes, "A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity," J. Immunol. Methods 15:61-69 (1988) copyright Elsevier.
Decodts et al., "Suicide inhibitors of proteases. Lack of activity of halomethyl derivatives of some aromatic lactams," Eur. J. Med. Chem 18: 107-111 (1983).
Desimoni et al., "Catalysis with Inorganic Cations. V<SUP>1 </SUP>Intramolecular Hetero Diels-Alder versus Ene Reactions: Effect of Magnesium perchlorate on Chemoselectivity,"Tetrahedron 52(36) 12009-12018 (1996) 8 Pergamon.
Dickson et al., "13. Tyrosine kinase receptor-nuclear protooncogene interactions in breast cancer," Cancer Treatment Res. 61:249-273 (1992) 8 Kluwer Academic Publishers.
Elliott and Rivers, "Reduction of Some Oxindolylidene Derivatives to 3-Substituted Oxindoles by Sodium Borohydride," J. Med. Chem. 29:2438-2440 (1964).
Elliott et al., "1-methyl-2-(3-oxindolidenmethyl)-pyridinium," Journal of Organic Chemistry 29:2438-2440 (1964) Database Crossfire, Beilstein Reference No. 5-24.
Fantl et al., "Distinct Phosphotyrosines on a Growth Factor Receptor Bind to Specific Molecules That Mediate Different Signaling Pathways," Cell 69:413-423 (1992) 8 Cell Press.
Fendly et al., Characterization of Murine Monoclonal Antibodies Reactive to Either the Human Epidermal Growth Factor Receptor or HER2/neu Gene Product, Cancer Research 50:1550-1558, 1990.
Ferrara and Henzel, "Pituitary Follicular Cells Secrete a Novel Heparin-Binding Growth Factor Specific for Vascular Endothelial Cells," Biochemical and Biophysical Research Comm., 161:851-858,1989.
Fingl and Woodbury, "Chapter 1-General Principles," in The Pharmacological Basis of Therapeutics 5th edition, Goldman and Gilman editors, MacMillan Publishing Co., Inc., New York, pp. 1-46 (1975) 8 MacMillan Publishing Co. Inc.
Fischer et al., Beilsteins Handbuch Der Organischen Chemie, Band 2, vol. 22, p. 231, 1953.
Fischer, H., "The Pyrroles, Paper 4: Pyrrole Aldehyde (II) and Pyrrole Nitrile," Zerweck, W. Chemische Berichte, (1923), pp. 519-527, vol. 55.
Floege et al., "Factors involved in the regulation of mesangial cell proliferationin vitro and in vivo," Kidney International 43:S47-S54 (1993) 8 International Society of Nephrology.
Floege et al., "Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangloproliferative glomerulonephritis," Kidney International 43:369-380 (1983) 8 International Society of Nephrology.
Folkman and Shing, "Angiogenesis," J. Biol. Chem. 267:10931-10934 (1992) 8 The American Society for Biochemistry and Molecular Biology.
Folkman, "Angiogenesis in Psoriasis: Therapeutic Implications," J. Invest. Dermatol. 59:40-43 (1973) copyright The Williams & Wilkins Co.
Folkman, "Ch. 24. Angiogenesis," Congress of Thrombosis and Haemostasis (Verstraete et al., eds.) Leuven University Press, Leuven pp. 583-596 (1987).
Folkman, "Tumor Angiogenesis: Therapeutic Implications," New England J. Medicine 285:1182-1186 (1971).
Folkman, "What is the Evidence that Tumors are Angiogenesis Dependent?" Journal of the National Cancer Institute 82:4-6 (1990).
Gazit et al., "Tyrphostins. 2. Heterocyclic and beta-Substituted Benzylidenemalononitrile Tyrphostins and Potent Inhibitors of EGF Receptor and ErbB2/neu Tyrosine Kinases," J. Med. Chem. 34:1896-1907 (1991) copyright Am. Clem. Soc.
Gennaro (editor), Remington's Pharmaceutical Sciences (1990) (Table of Contents Only).
Goldring and Goldring, "Cytokines and Cell Growth Control," Critical Reviews in Eukaryotic Gene Expression 1:301-326 (1991).
Gottardis et al., "Estradiol-Stimulated Growth of MCF-7 Tumors Implanted in Athymic Mice: A Model to Study the Tumoristatic Action of Tamoxifen," J. Steroid Biochem, 30:311-314 (1988) 8 Pergamon Press.
Graziani et al., "Hepatocyte Growth Factor/Scatter Factor Stimulates the Ras-Guanine Nucleotide Exchanger," The Journal of Biological Chemistry 268:9165-9168 (1993) 8American Society for Biochemistry and Molecular Biology.
Hayler et al., Development of Large-Scale Syntheses of Ropinirole in the Pursuit if a Manufacturing Process, Organic Process Research & Development 2(1) 3-9 (1998) 8The American Chemical Society and Royal Society of Chemistry.
Hewgill and Stewart, "Phenanthrene-4,5-quinones: a Synthesis of Morphenol," J. Chem. Soc. Perkin Trans. l:1305-1311 (1988).
Hirao et al., "Rhodium-Catalyzed Carbonylation of 2-Alkynylaniline: Syntheses of 1,3-Dihydroindol-2-ones," Tetrahedron Letters 36(35)(1995)8Pergamon.
Hodges et al., "Chemical and biological properties of some oxindolidyl-3-methines," Canadian J. Chemistry 46:2189-2194 (1968).
Honegger et al., "Point Mutation at the ATP Binding Site of EGF Receptor Abolishes Protein-Tyrosine Kinase Activity and Alters Cellular Routing," Cell 51:199-209 (1987) 8 Cell Press.
Houck et al., "Dual Regulation of Vascular Endothelial Growth Factor Bioavailability by Genetic and Proteolytic Mechanisms," J. Biol. Chem. 267:26031-26037 (1992)8 American Society for Biochemistry and Molecular Biology, Inc.
Howard et al., "Synthesis and aldose reductase inhibitory activity of substituted 2(1H)-benzimidazolone- and oxindole-1-acetic acids," Eur. J. Med. Chem. 27:779-789 (1992) 8 Elsevier, Paris.
Howard, Harry R., "Lactam Derivatives," Provisional U.S. Appl. No. 60/015,134, 1996.
Hu et al., "Interaction of Phosphatidylinositol 3-Kinase-Associated p85 with Epidermal Growth Factor and Platelet-Derived Growth Factor Receptors," Molecular and Cellular Biology 12:981-990, (1992).
Ijaz et al., "The Conversion of o,beta-Dinitrostyrenes into Indoles and the Preparation of Oxindole Quinones," J. Chem. Res. (S): 116 (1990).
Jellinek et al., "Inhibition of Receptor Binding by High-Affinity RNA Ligands to Vascular Endothelial Growth Factor," Biochemistry 33:10450-10456 (1994) 8 American Chemical Society.
Kashishian and Cooper, "Phosphorylation Sites at the C-terminus of the Platelet-Derived Growth Factor Receptor Bind Phospholipase Cgamma1," Molecular Biology of the Cell 4:49-57 (1993) 8 The American Society for Cell Biology.
Kashishian et al., "Phosphorylation sites in the PDGF receptor with different specificities for binding GAP and P13 kinase in vivo," The EMBO Journal 11:1373-1382 (1992).
Kato et al., "Simultaneous Determination of Amfenac Sodium and its Metabolite (7-Benzoyl-2-Oxindole) in Human Plasma by High-Performance Liquid Chromatography," Journal of Chromatography 616:67-71 (1993) 8Elsevier Science.
Katritzky et al., "Color and Constitution. Part 8[1]. Some Novel Dyestuffs Containing Indoxyl Residues," J. Heterocyclic Chem. 25:1287-1292 (1988).
Kazlauskas et al., "The 64-kDa protein that associates with the platelet-derived growth factor receptor beta subunit via Tyr-1009 is the SH2-containing phosphotyrosine phosphatase Syp," Proc. Natl. Acad. Sci. USA 90:6939-6942 (1993).
Kendall and Thomas, "Inibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor," Proc. Natl. Acad. Sci. USA 90:10705-10709 (1993).
Khalil and Abdel-Rahman, "Synthesis of New Mero- and Asymmetrical Pyrazolo-Monomethine Cyanine Dyes," J. Indian Chem. Soc. 54:904-907 (1977) 8The Indian Chemical Society.
Kikumoto et al., "The Reactions of Oxindoles and Isatin with Nitrobenzyl Chlorides," Tetrahedron 22: 3337-3343 (1966) 8Pergamon Press Ltd.
Kim et al., "Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo" Nature 362:841-844 (1993).
Kinsella et al., "Protein Kinase C Regulates Endothelial Cell Tube Formation on Basement Membrane Matrix, Matrigel," Exp. Cell Research 199:56-62 (1992) 8 Academic Press, INc.
Klagsbrun and Soker, "VEGF/VPF: the angiogenesis factor found?" Current Biology 3:699-702 (1993) 8Current Biology.
Kobayashi et al., "Anti-tumor Activity of Indole Derivatives," Yakugaku Zasshi 97:1033-1039 (1977).
Koch et al., "SH2 and SH3 Domains: Elements That Control Interactions of Cytoplasmic Signaling Proteins," Science 252:668-674 (1991).
Kohler and Milstein, "Continuous cultures of fused cells secreting antibody of predefined specificity," Nature 256:495-497 (1975).
Komada and Kitamura, "The cell dissociation and motility triggered by scatter factor/hepatocyte growth factor are mediated through the cytoplasmic domain of the c-Met receptor," Oncogene 8:2381-2390 (1993).
Korc et al., "Overexpression of the Epidermal Growth Factor Receptor in Human Pancreatic Cancer is Associated with Concomitant Increases in the Levels of Epidermal Growth Factor and Transforming Growth Factor Alpha," J. Clin. Invest. 90:1352-1360 (1992) copyright The American Society for Clinical Investigation, Inc.
Korzeniewski and Callewaert, "An Enzyme-Release Assay for Natural Cytotoxicity," J. Immunol. Methods 64:313-320 (1983) 8 Elsevier Science Publishers.